Effects of chia seed (Salvia hispanica L.) supplementation on cardiometabolic health in overweight subjects: a systematic review and meta-analysis of RCTs.

Background: Obesity is a significant public health issue associated with various chronic diseases. Research has indicated that chia seeds have the potential to improve cardiometabolic health. However, due to the diversity of research and inconsistencies in study design, further investigation is need...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition & Metabolism Vol. 21; no. 1; pp. 1 - 16
Autores principales: Karimi, Mehdi, Pirzad, Samira, Shirsalimi, Niyousha, Ahmadizad, Sajad, Hashemi, Seyyed Mohammad, Karami, Shaghayegh, Kazemi, Kimia, Shahir-Roudi, Erfan, Aminzadeh, Anita
Formato: meta analysis research systematic review tables/charts Journal Article
Publicado: BioMed Central 9/16/2024
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=179668659&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 179668659
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17437075
        1CYX
      jtl: Nutrition & Metabolism
      issn: 17437075
      maglogo: N
    pubinfo:
      dt: 9/16/2024
      vid: 21
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        179668659
        179668659
        179668659
        10.1186/s12986-024-00847-3
        179668659
      ppf: 1
      ppct: 15
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Effects of chia seed (Salvia hispanica L.) supplementation on cardiometabolic health in overweight subjects: a systematic review and meta-analysis of RCTs.
      aug:
        au:
          Karimi, Mehdi
          Pirzad, Samira
          Shirsalimi, Niyousha
          Ahmadizad, Sajad
          Hashemi, Seyyed Mohammad
          Karami, Shaghayegh
          Kazemi, Kimia
          Shahir-Roudi, Erfan
          Aminzadeh, Anita
        affil: https://ror.org/03edafd86 Bogomolets National Medical University (NMU), Kyiv, Ukraine
      sug:
        subj:
          Seeds Pharmacodynamics
          Cardiometabolic Risk Factors
          Obesity Drug Therapy
          Risk Assessment
          Treatment Outcomes
          Human
          Systematic Review
          Meta Analysis
          PubMed
          Embase
          Subject Headings
          Biological Markers Blood
          Data Analysis Software
          C-Reactive Protein Blood
          Systolic Pressure
          Therapeutic Exercise
          Life Style Changes
          Record Review
      ab: Background: Obesity is a significant public health issue associated with various chronic diseases. Research has indicated that chia seeds have the potential to improve cardiometabolic health. However, due to the diversity of research and inconsistencies in study design, further investigation is needed to fully understand their clinical effects on overweight individuals. This review aims to comprehensively analyze the available evidence on the effects of chia seeds on cardiometabolic indices in overweight populations through a meta-analysis. Methods: A comprehensive literature search was performed across PubMed, Web of Science, Scopus, and Embase databases from their inception until 01-03-2024 to identify randomized controlled trials (RCTs) evaluating the effect of chia on cardiometabolic indices in overweight subjects. The search strategy incorporated both Medical Subject Headings (MeSH). Following the screening, ten RCTs were finally included. The data, including subject characteristics, study design, and changes in serum biomarkers, were extracted and analyzed using Stata software version 18. Results: The meta-analysis results reveal that chia supplementation no significant changes in lipid profile, including triglycerides (TG) (MD: − 5.80 mg/dL, p = 0.47), total cholesterol (TC) (MD: − 0.29 mg/dL, p = 0.95), high-density lipoprotein (HDL) (MD: 1.53 mg/dL, p = 0.33), and low-density lipoprotein (LDL) (MD: 0.63 mg/dL, p = 0.88). Similarity fasting blood glucose (FBG) (MD: − 0.03 mg/dL, p = 0.98), hemoglobin A1c (HbA1c) (MD: − 0.13%, p = 0.13), and insulin levels (MD: 0.45 µIU/mL, p = 0.78). However, chia seed supplementation was associated with a significant reduction in C-reactive protein (CRP) (MD: − 1.18 mg/L, p < 0.0001), but no significant changes were observed in interleukin-6 (IL-6) (MD: − 0.15, p = 0.70) or tumor necrosis factor-alpha (TNF-α) (MD: 0.03, p = 0.91). There was no significant effect on body mass index (BMI) (MD: 0.1 kg/m2, p = 0.91), but a significant reduction in waist circumference (WC) (MD: − 2.82 cm, p < 0.001) was noted. Additionally, chia seed supplementation resulted in a significant reduction in systolic blood pressure (BP) (MD: − 3.27 mmHg, p = 0.03), though diastolic BP changes were non-significant (MD: − 2.69 mmHg, p = 0.09). The studies showed low to moderate heterogeneity in outcome measures, with I2 < 50%. Conclusion: Chia seed supplementation does not significantly impact most lipid profile parameters and glycemic markers. However, it shows potential benefits in reducing WC, BP, and CRP. While chia seeds can be a valuable addition to cardiometabolic health management, they should be part of a broader health strategy that includes a balanced diet, exercise, and lifestyle modifications for optimal results.
      pubtype: Academic Journal
      doctype:
        meta analysis
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N